Financhill
Back

Citius Oncology Stock Predictions

Citius Oncology Stock Forecast

  • Is Citius Oncology Stock Undervalued?
    The current Citius Oncology [CTOR] share price is $1.22. The Score for CTOR is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • CTOR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Citius Oncology Stock Go Up Next Year?

Data Unavailable

Citius Oncology Stock Rating

Data Unavailable

Citius Oncology Stock Price History

Is CTOR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTOR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:

52-Week Data

52-Week High:
4.42
52-Week Low:
0.93

Prediction Charts

Market Cap:
86.91M
Price in USD:
1.22
Volume:
74.52K
Beta:
-3.00

Technical Analysis

SMA50:
1.34
SMA100:
0.00
SMA200:
0.00
52-Wk Change:
0%

Stock Predictions

  • Is Citius Oncology stock public?
    Yes, Citius Oncology is a publicly traded company.
  • What is the Citius Oncology stock quote today?
    The Citius Oncology stock price is 1.22 USD today.
  • How to buy Citius Oncology stock online?
    You can buy Citius Oncology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 1.23 1.19 1.25 1.17
Oct-28 1.21 1.17 1.21 1.13
Oct-29 1.20 1.21 1.27 1.19
Oct-30 1.18 1.21 1.27 1.15
Oct-31 1.22 1.19 1.25 1.15
Nov-1 1.16 1.14 1.21 1.14
Nov-4 1.11 1.03 1.12 1.01
Nov-5 1.02 1.19 1.20 1.02
Nov-6 1.16 1.18 1.32 1.13
Nov-7 1.22 1.26 1.31 1.18
Nov-8 1.30 1.27 1.39 1.21
Nov-11 1.29 1.36 1.45 1.18
Nov-12 1.39 1.30 1.41 1.25
Nov-13 1.35 1.22 1.36 1.18

Citius Oncology Earnings

Data Unavailable

Citius Oncology Forecast Revenue Growth

Data Unavailable

* Citius Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.